相似文献
1
Treatment of uncomplicated gonorrhoea in women with a combination of rifampicin and erythromycin.
Br J Vener Dis. 1984 Oct;60(5):309-11. doi: 10.1136/sti.60.5.309.
2
Treatment of gonococcal urethritis in men with a rifampicin-erythromycin combination.
Sex Transm Dis. 1982 Oct-Dec;9(4):208-11. doi: 10.1097/00007435-198210000-00011.
3
Rifampicin-erythromycin combination for the treatment of gonococcal urethritis in men.
Southeast Asian J Trop Med Public Health. 1984 Sep;15(3):360-3.
4
Single dose cefoxitin in treating uncomplicated gonorrhoea caused by penicillinase producing Neisseria gonorrhoeae (PPNG) and non-PPNG strains.
Genitourin Med. 1986 Aug;62(4):224-7. doi: 10.1136/sti.62.4.224.
5
The combination of rifampicin-erythromycin in the treatment of gonococcal urethritis in men.
J Med Assoc Thai. 1985 Nov;68(11):579-82.
6
[New recommendations in the treatment of genital infections caused by Neisseria gonorrhoeae in Puerto Rico].
Bol Asoc Med P R. 1985 Aug;77(8):343-4.
7
Open study of the safety and efficacy of a single oral dose of azithromycin for the treatment of uncomplicated gonorrhoea in men and women.
J Antimicrob Chemother. 1993 Jun;31 Suppl E:193-8. doi: 10.1093/jac/31.suppl_e.193.
8
9
Hyperendemic penicillinase-producing Neisseria gonorrhoeae genital infections in an inner city population.
J Adolesc Health. 1995 Jan;16(1):41-4. doi: 10.1016/1054-139X(94)00042-D.
10
Azithromycin in the treatment of sexually transmitted disease.
J Antimicrob Chemother. 1990 Jan;25 Suppl A:109-14. doi: 10.1093/jac/25.suppl_a.109.
引用本文的文献
1
Rifampicin Resistance Associated with Mutations in Neisseria gonorrhoeae Clinical Strains Isolated in Austria, 2016 to 2020.
Microbiol Spectr. 2022 Jun 29;10(3):e0275721. doi: 10.1128/spectrum.02757-21. Epub 2022 Jun 9.
2
In vitro synergy testing of novel antimicrobial combination therapies against Neisseria gonorrhoeae.
J Antimicrob Chemother. 2014 Jun;69(6):1572-8. doi: 10.1093/jac/dkt540. Epub 2014 Jan 26.
3
Antimicrobial susceptibility testing of Neisseria gonorrhoeae and implications for epidemiology and therapy.
Clin Microbiol Rev. 1993 Jan;6(1):22-33. doi: 10.1128/CMR.6.1.22.
4
Use of rifampin in nonstaphylococcal, nonmycobacterial disease.
Antimicrob Agents Chemother. 1993 Jan;37(1):1-7. doi: 10.1128/AAC.37.1.1.
本文引用的文献
1
Treatment of gonococcal urethritis in men with a rifampicin-erythromycin combination.
Sex Transm Dis. 1982 Oct-Dec;9(4):208-11. doi: 10.1097/00007435-198210000-00011.
2
Penicillinase-producing Neisseria gonorrhoeae.
N Engl J Med. 1982 Dec 30;307(27):1706. doi: 10.1056/NEJM198212303072712.
3
Penicillinase-producing Neisseria gonorrhoeae in Great Britain, 1977-81: alarming increase in incidence and recent development of endemic transmission.
Br Med J (Clin Res Ed). 1982 Jul 31;285(6338):337-40. doi: 10.1136/bmj.285.6338.337.
4
Evidence that rifampicin can be used safely for non-tuberculous diseases.
Thorax. 1980 Oct;35(10):788-91. doi: 10.1136/thx.35.10.788.
5
Treatment of gonorrhoea with single oral doses of rifampicin.
Br Med J. 1968 Dec 14;4(5632):681-2. doi: 10.1136/bmj.4.5632.681.
6
Rifampicin compared with penicllin in the treatment of gonorrhea.
Chemotherapy. 1971;16(5):319-25. doi: 10.1159/000220742.
7
Comparison of erythromycin stearate and oxytetracycline in the treatment of non-gonococcal urethritis: their efficacy against Chlamydia trachomatis.
Scott Med J. 1977 Dec;22(5):375-9. doi: 10.1177/00369330770220S106.
8
Comparison of erythromycin base and estolate in gonococcal urethritis.
JAMA. 1977 Sep 26;238(13):1371-3.
9
Penicillinase-producing Neisseria gonorrhoeae.
Lancet. 1976 Oct 9;2(7989):793.
Zotero 插件